𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The effect of an interleukin-1 receptor antagonist protein on type ii collagen–induced arthritis and antigen-induced arthritis in mice

✍ Scribed by Paul H. Wooley; Janey D. Whalen; Darryl L. Chapman; Ann E. Berger; Karen A. Richard; Danielle G. Aspar; Nigel D. Staite

Publisher
John Wiley and Sons
Year
1993
Tongue
English
Weight
988 KB
Volume
36
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mice transgenic for intracellular interl
Mice transgenic for intracellular interleukin-1 receptor antagonist type 1 are protected from collagen-induced arthritis
✍ Gaby Palmer; Dominique Talabot-Ayer; Ildiko Szalay-Quinodoz; Michel Maret; Willi 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 198 KB

## Abstract Interleukin‐1 receptor antagonist (IL‐1Ra) is a natural IL‐1 inhibitor, which competitively inhibits binding of IL‐1 to its receptors. IL‐1Ra is produced as four different isoforms, one secreted (sIL‐1Ra) and three intracellular (icIL‐1Ra1, 2, 3), derived from the same gene. We previous

Effectiveness of the soluble form of the
Effectiveness of the soluble form of the interleukin-1 receptor accessory protein as an inhibitor of interleukin-1 in collagen-induced arthritis
✍ R. L. Smeets; F. A. J. van de Loo; L. A. B. Joosten; O. J. Arntz; M. B. Bennink; 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 457 KB 👁 2 views

## Abstract ## Objective To investigate whether the soluble form of interleukin‐1 (IL‐1) receptor accessory protein (sIL‐1RAcP), whose physiologic function remains to be established, can serve as a specific inhibitor of IL‐1 signaling in vitro, and to evaluate its applicability in collagen‐induced

The type II decoy receptor of IL-1 inhib
The type II decoy receptor of IL-1 inhibits murine collagen-induced arthritis
✍ Natacha Bessis; Laurence Guéry; Alberto Mantovani; Annunciata Vecchi; John E. Si 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 129 KB 👁 1 views

IL-1 is a key cytokine involved in the inflammatory response. The type II receptor of IL-1 (IL-1RII) acts as a decoy receptor, binding and inhibiting the effect of IL-1. This study was undertaken to establish whether IL-1RII can ameliorate collagen-induced arthritis, a model of inflammatory arthriti